| T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma K Woroniecka, P Chongsathidkiet, K Rhodin, H Kemeny, C Dechant, ... Clinical Cancer Research 24 (17), 4175-4186, 2018 | 518 | 2018 |
| T-cell dysfunction in glioblastoma: applying a new framework KI Woroniecka, KE Rhodin, P Chongsathidkiet, KA Keith, PE Fecci Clinical Cancer Research 24 (16), 3792-3802, 2018 | 265 | 2018 |
| Chronic periodontitis genome-wide association studies: gene-centric and gene set enrichment analyses K Rhodin, K Divaris, KE North, SP Barros, K Moss, JD Beck, ... Journal of dental research 93 (9), 882-890, 2014 | 110 | 2014 |
| Targeting PD-L1 initiates effective antitumor immunity in a murine model of Cushing disease HR Kemeny, AA Elsamadicy, SH Farber, CD Champion, SJ Lorrey, ... Clinical Cancer Research 26 (5), 1141-1151, 2020 | 50 | 2020 |
| 4-1BB agonism averts TIL exhaustion and licenses PD-1 blockade in glioblastoma and other intracranial cancers KI Woroniecka, KE Rhodin, C Dechant, X Cui, P Chongsathidkiet, ... Clinical Cancer Research 26 (6), 1349-1358, 2020 | 49 | 2020 |
| Delay in adjuvant chemotherapy and survival advantage in stage III colon cancer MC Turner, NE Farrow, KE Rhodin, Z Sun, MA Adam, CR Mantyh, ... Journal of the American College of Surgeons 226 (4), 670-678, 2018 | 49 | 2018 |
| The effect of tumor size and histologic findings on outcomes after segmentectomy vs lobectomy for clinically node-negative non-small cell lung cancer V Raman, OK Jawitz, SL Voigt, KE Rhodin, TA D’Amico, DH Harpole, ... Chest 159 (1), 390-400, 2021 | 41 | 2021 |
| The immunotherapeutic landscape in non–small cell lung cancer and its surgical horizons KE Rhodin, AJ Rucker, NE Ready, TA D'Amico, SJ Antonia The Journal of Thoracic and Cardiovascular Surgery 159 (4), 1616-1623, 2020 | 28 | 2020 |
| Evolution of minimally invasive surgery for rectal cancer: update from the national cancer database B Gilmore, MA Adam, K Rhodin, MC Turner, B Ezekian, CR Mantyh, ... Surgical Endoscopy 35, 275-290, 2021 | 21 | 2021 |
| Oncolytic viruses in melanoma C Robinson, MM Xu, SK Nair, GM Beasley, KE Rhodin Frontiers in bioscience (Landmark edition) 27 (2), 63, 2022 | 19 | 2022 |
| The relationship between lymph node ratio and survival benefit with adjuvant chemotherapy in node-positive esophageal adenocarcinoma V Raman, OK Jawitz, NE Farrow, SL Voigt, KE Rhodin, CFJ Yang, ... Annals of surgery 275 (3), e562-e567, 2022 | 14 | 2022 |
| Patterns and impact of fragmented care in stage II and III gastric cancer KE Rhodin, V Raman, A Eckhoff, A Liu, J Creasy, DP Nussbaum, ... Annals of surgical oncology 29 (9), 5422-5431, 2022 | 11 | 2022 |
| Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook PC Gedeon, CD Champion, KE Rhodin, K Woroniecka, HR Kemeny, ... Expert review of clinical pharmacology 13 (10), 1147-1158, 2020 | 11 | 2020 |
| Adjuvant radiation therapy for clinical stage III melanoma in the modern therapeutic era RJ Straker, Y Song, J Sun, AB Shannon, LS Cohen, E Muradova, H Daou, ... Annals of Surgical Oncology 28, 3512-3521, 2021 | 10 | 2021 |
| Patterns of use of induction therapy for T2N0 esophageal cancer KE Rhodin, V Raman, OK Jawitz, SL Voigt, NE Farrow, DH Harpole, ... The Annals of thoracic surgery 111 (2), 440-447, 2021 | 10 | 2021 |
| Trends in receipt of adjuvant chemotherapy and its impact on survival in resected biliary tract cancers KE Rhodin, A Liu, A Bartholomew, R Kramer, A Parameswaran, H Uronis, ... Annals of Surgical Oncology 30 (8), 4813-4821, 2023 | 6 | 2023 |
| Implementation of a surgical oncology disparities curriculum for preclinical medical students KE Rhodin, CS Hong, LA Olivere, EP Howell, VK Giri, KA Mehta, ... journal of surgical research 253, 214-223, 2020 | 6 | 2020 |
| The effect of timing of adjuvant therapy on survival after esophagectomy KE Rhodin, V Raman, OK Jawitz, BC Tong, DH Harpole, TA D’Amico The Annals of thoracic surgery 110 (3), 1023-1029, 2020 | 6 | 2020 |
| The effect of center esophagectomy volume on outcomes in clinical stage I to III esophageal cancer KE Rhodin, V Raman, CW Jensen, L Kang, DH Harpole Jr, TA D’Amico, ... Annals of Surgery 278 (1), 79-86, 2023 | 5 | 2023 |
| Multi-institutional care in clinical stage II and III esophageal cancer KE Rhodin, V Raman, CW Jensen, L Kang, DP Nussbaum, BC Tong, ... The Annals of thoracic surgery 115 (2), 370-377, 2023 | 5 | 2023 |
